AzTrials
AzTrials

PregnancyNCT07134959

Exercise Benefits and Barriers in Pregnancy

An observational study of Pregnancy, run by Ordu University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to examine the validity and reliability of the Exercise Benefits/Barriers Scale in pregnant women. It will contribute to raising awareness about engaging in physical activity and exercise during pregnancy in the pregnant population through the applied questionnaires. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Pregnancy
How many people
300 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Sep 2025to 1 Dec 2025
How long will I take part?
5 Days
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: Ordu University Training and Research Hospital

Who may be able to join

  • Being between 18 and 45 years of age,
  • Being in the second or third trimester of pregnancy,
  • Being literate in Turkish,
  • Willingness to participate in the study.
  • Being between 18 and 45 years of age,
  • Female sex,
  • Being literate in Turkish,
  • Willingness to participate in the study.

Who cannot join

  • Presence of pregnancy complications that may prevent physical activity and exercise (e.g., preeclampsia, vaginal bleeding, heart disease),
  • Presence of orthopedic or neurological problems that may hinder participation in the study,
  • Presence of visual, auditory, or cognitive impairments severe enough to prevent participation in the study,
  • Multiple pregnancy.
  • Having a disease severe enough to prevent physical activity and exercise (e.g., endocrine and metabolic disorders, cardiopulmonary diseases),
  • Presence of orthopedic or neurological problems that may hinder participation in the study,
Show all 10Show fewer
  • Presence of visual, auditory, or cognitive impairments severe enough to prevent participation in the study,
  • Participation in another experimental or drug study during the study period,
  • Being pregnant or suspected of pregnancy,
  • Having experienced pregnancy, childbirth, or surgical intervention within the last six months.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Ordu Üniversitesi

    Ordu, Altınordu, 52000

Other trials in Turkey (Türkiye)

About this study

Official title: Validity and Reliability of Turkish Version Exercise Benefits/Barriers Scale in Pregnant Women

The aim of this study is to examine the validity and reliability of the Exercise Benefits/Barriers Scale in pregnant women. It will contribute to raising awareness about engaging in physical activity and exercise during pregnancy in the pregnant population through the applied questionnaires.

Read the detailed description

Regular physical activity (PA) and exercise during pregnancy help protect the health of both the mother and the baby by reducing the risk of excessive gestational weight gain, hypertension, gestational diabetes, venous problems, and birth-related complications. They also have positive effects on sleep, stress, anxiety, depression, and overall quality of life. However, PA participation rates during pregnancy are low and tend to decline as pregnancy progresses through the trimesters. Hormonal and physiological changes, weight gain, fatigue, and psychological disturbances are among the main factors limiting participation. Therefore, identifying the barriers to PA during pregnancy and developing strategies to address them is essential. Assessing perceptions of the benefits and barriers to exercise can guide interventions aimed at increasing PA levels. This study aims to determine the validity and reliability of the Exercise Benefits/Barriers Scale in pregnant women, with the expectation that its findings will provide valuable evidence for both scientific research and clinical practice.

Conditions
Pregnancy
Keywords
pregnancy, exercise, Questionnaire, physical activity
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07134959
Study groupRoleWhat they receive
study grouppregnant women
control grouphealthy non-pregnant women

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Exercise Benefits/Barriers Scale (EBBS):

    Developed in 1987 by Sechrist et al. to assess individuals' perceptions of the benefits of and barriers to exercise (Sechrist et al., 1987). It is a Likert-type scale with responses rated from "4 = strongly agree" to "1 = strongly disagree." The scale consists of two subscales: EBBS-Benefits and EBBS-Barriers. The EBBS-Benefits subscale contains 29 items, while the EBBS-Barriers subscale contains 14 items. In the EBBS-Barriers subscale, lower scores indicate a higher perceived barrier to exercise, whereas in the EBBS-Benefits subscale, higher scores indicate a more positive perception of exercise. The validity and reliability of the Turkish version were demonstrated by Saraç et al. (2024), with Cronbach's alpha coefficients of 0.95 for the EBBS-Benefits subscale and 0.82 for the EBBS-Barriers subscale (Saraç et al., 2024).

    Measured: At baseline and 5 days after the first assessment

Secondary outcomes (5)
  1. Barriers to Physical Activity During Pregnancy Scale

    Developed by Amiri-Farahani et al. (2021) to evaluate barriers to physical activity among pregnant women. The scale consists of 29 items and four subdimensions, with each item scored on a 5-point Likert scale (1 = strongly disagree, 2 = disagree, 3 = neutral, 4 = agree, 5 = strongly agree). Higher scores indicate greater barriers to physical activity (Amiri-Farahani et al., 2021). The validity and reliability of the Turkish version were confirmed by Ataman Bor and Hanligil, with Cronbach's alpha coefficients reported as follows: total scale, 0.91; pregnancy-related personal barriers, 0.88; non-pregnancy-related personal barriers, 0.89; interpersonal barriers, 0.87; environmental barriers, 0.80 (Bor \& Hanligil, 2024).

    Measured: at baseline

  2. Pregnancy Physical Activity Questionnaire (PPAQ)

    Developed by Chasan-Taber et al. (2004), this semi-quantitative questionnaire asks participants to report the amount of time spent on 32 different activities. These include household/caregiving activities (13 items), occupational activities (5 items), sports/exercise (8 items), transportation (3 items), and inactivity (3 items). For each activity, participants indicate the amount of time they typically spend per day or week during their current trimester. Time intervals range from 0 to 6 or more hours per day and 0 to 3 or more hours per week. An open-ended section at the end allows participants to list other activities not included in the questionnaire. Weekly total energy expenditure is calculated as MET-hours/week (Chasan-Taber et al., 2004). The Turkish validity and reliability study was conducted by Çırak et al. (2015).

    Measured: at baseline

  3. International Physical Activity Questionnaire-Short Form (IPAQ-SF)

    Physical activity levels will be assessed using the Turkish version of the IPAQ-SF, which has demonstrated validity and reliability (Saglam et al., 2010). The questionnaire consists of seven items evaluating time spent in walking, moderate-intensity, and vigorous-intensity activities, as well as one separate question assessing time spent sitting. Scoring involves calculating total minutes and days for walking, moderate, and vigorous activities. MET-minutes are computed by multiplying the minutes spent in each activity by its MET value (vigorous activity = 8 METs, moderate activity = 4 METs, walking = 3.3 METs). Participants are classified into three categories based on total MET-minutes: "inactive," "minimally active," and "highly active" (Saglam et al., 2010).

    Measured: at baseline

  4. Pregnancy Exercise Self-Efficacy Questionnaire

    This 10-item questionnaire assesses pregnant women's perceived ability and motivation to engage in physical activity under various circumstances. Adapted from the Exercise Self-Efficacy Scale, it was developed by Brand et al. to explain and predict changes in exercise behavior. A 5-point Likert scale is used (1 = strongly disagree to 5 = strongly agree), with total scores ranging from 10 to 50. Scores are categorized as follows: low self-efficacy, 10-17 points; moderate self-efficacy, 18-34 points; high self-efficacy, 35-50 points (Brand et al., 2013). The Turkish validity and reliability study was conducted by Üzelpasaci et al. (2023), with a Cronbach's alpha of 0.889.

    Measured: at baseline

  5. Visual Analog Scale (VAS) for Kinesiophobia

    The severity of kinesiophobia among pregnant participants will be assessed using a vertical 0-10 cm Visual Analog Scale through the following question:

    • "I am afraid that exercising during pregnancy might harm my baby" (0 = not afraid at all, 10 = extremely afraid)

    Participants will be asked to mark a point on the VAS, and the distance from 0 will be measured with a ruler.

    Measured: at baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2025
  2. Study start1 Sep 2025
  3. Primary completion25 Nov 2025
  4. Study completion1 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
300 participants (actual)
Target duration
5 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT07134959
Sponsor's protocol ID
E-1146814
Status last verified
Jan 2026
First submitted
14 Aug 2025
Last updated
22 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Pregnancy, run by Ordu University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Exercise Benefits/Barriers Scale (EBBS): (time frame: At baseline and 5 days after the first assessment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in